Supplemental material
Journal of Medical Economics
Volume 24, 2021 - Issue 1
Hematology
Adult lifetime cost of hemophilia B management in the US: payer and societal perspectives from a decision analytic model
, , 
, , , , , , & show all
Konrad Maruszczykb HCD Economics, Daresbury, UKhttps://orcid.org/0000-0002-0173-5020
https://orcid.org/0000-0002-0173-5020, Greg Guzauskasb HCD Economics, Daresbury, UK;c CHOICE Institute, University of Washington, Seattle, WA, USAhttps://orcid.org/0000-0002-9095-1672
https://orcid.org/0000-0002-9095-1672, , , Antony P. Martinb HCD Economics, Daresbury, UKhttps://orcid.org/0000-0003-4383-6038
https://orcid.org/0000-0003-4383-6038, Jamie O’Harab HCD Economics, Daresbury, UK;e Faculty of Health and Social Care, University of Chester, Chester, UKhttps://orcid.org/0000-0001-8262-034X
https://orcid.org/0000-0001-8262-034X, Matt Stevensonf School of Health and Related Research, The University of Sheffield, Sheffield, UKhttps://orcid.org/0000-0002-3099-9877
https://orcid.org/0000-0002-3099-9877 & Michael Rechtg American Thrombosis and Hemostasis Network, Rochester, NY, USA;h The Hemophilia Center, Oregon Health & Science University, Portland, OR, USAhttps://orcid.org/0000-0002-2805-1016
https://orcid.org/0000-0002-2805-1016 show all
Related Research Data
Adult lifetime cost of hemophilia B management in the US: payer and societal perspectives from a decision analytic model
Source:
Taylor & Francis
Linking provided by
